Palmitamide monoethanolamide (MEA (sometimes PEA-MEA, but not a widely standardized abbreviation))

Palmitamide monoethanolamide is a fatty acid amide formed by the reaction of palmitic acid and monoethanolamine. It is primarily used as an emollient, thickener, antistatic agent, and conditioning ingredient in cosmetic and personal care products such as shampoos, conditioners, lotions, and creams. Its main function is to improve product texture and provide hydration by forming a protective film on skin or hair. In industrial settings it also serves as a nonionic surfactant due to its cleansing and emulsifying properties. While sometimes referenced alongside palmitoylethanolamide (PEA), which has documented anti-inflammatory effects via biological targets like PPAR-alpha receptors, palmitamide MEA itself is not recognized as a therapeutic target nor does it have established pharmacological activity for inflammation reduction in humans. Some sources mention "anti-inflammatory" or "irritation-reducing" properties when used topically, but these claims pertain more to its use profile than to direct molecular targeting relevant for drug discovery. Note: The query appears to conflate palmitoylethanolamide (PEA)—a bioactive endogenous lipid with anti-inflammatory effects mediated through specific receptors—with palmitic acid monoethanolamine ("palmitamide MEA"), which is mainly an industrial/cosmetic ingredient without evidence of being a validated therapeutic target. If you intended information about the pharmacologically active molecule palmitoylethanolamide, please clarify; otherwise "inflammation reduction via palmitamide MEA" does not correspond to any known receptor/target entity.

Other names

Palmitamide MEAN-(2-Hydroxyethyl)palmitamidePalmitic acid monoethanolamideHexadecanamide, N-(2-hydroxyethyl)-N-Hydroxyethyl-N-methylpalmitamide (for methylated variant)PEA Complex (in some cosmetic contexts)